Reliance Global is an insurance brokerage that operates a network of independent agencies while building "insurtech" software to automate the quoting process for agents and shoppers. The company generates roughly $13 million in annual revenue but is in the process of doubling that scale through the acquisition of Spetner Associates. Following a multi-year period of heavy losses, the business reached a milestone in late 2024 by reporting its first quarter of positive adjusted earnings before interest, taxes, and other items.
The core bet on Reliance Global is that its "OneFirm" strategy successfully merges dozens of small, scattered agencies into a single efficient operation that can finally cover its corporate overhead. By moving these agents onto its RELI Exchange software, the company aims to cut administrative costs while giving small brokers the same digital tools used by national giants. If the company can integrate the $28 million Spetner revenue stream without ballooning its costs, the math for a micro-cap turnaround becomes clear.
We view the stock as a high-potential turnaround play because the current market valuation does not reflect the significant revenue growth coming from new acquisitions. While the small size of the company makes it risky, the recent shift toward positive adjusted earnings suggests the worst of the cash burn is over. One quarter of failing to integrate the Spetner revenue would be enough to break the case.
What does it do?
Reliance Global is a growth-stage business that earns money by taking a commission on every insurance policy sold through its network of partner agencies. The company buys up small, local insurance agencies and moves them onto its central software platform, RELI Exchange, which allows them to quote policies for home, auto, and health insurance in minutes. This mechanism lets small agents work faster and access more insurance carriers than they could on their own, while Reliance takes a cut of the resulting premiums.
Where does revenue come from?
The vast majority of revenue comes from recurring commissions paid by insurance carriers for the maintenance and renewal of active policies. This is split between retail commissions from policies sold directly to consumers and wholesale commissions from other brokers who use the Reliance network. The company also generates fee-based revenue through its technology platform, RELI Exchange, which offers business tools to independent agencies.
Who are its customers?
Reliance Global serves thousands of independent insurance agents and everyday consumers looking for competitive quotes through its 5minuteinsure.com portal. The company recently reported a 72% increase in health insurance policies written through its network during the 2025 open enrollment period, highlighting its reach into the individual consumer market. While the total number of partner agencies fluctuates as the network expands, the business is anchored by the Spetner acquisition, which serves a large base of commercial and employee benefits clients.
What gives it staying power?
The company has limited staying power today because the insurance brokerage market is highly competitive and has low barriers to entry. Its primary advantage is the "switching cost" for agents who rely on the RELI Exchange software to manage their daily workflows and access specific carriers.
Where is it headed?
The company is making a major strategic bet on EZRA International Group, a holding platform designed to buy controlling stakes in high-growth technology businesses outside of insurance. This includes recent moves into medical diagnostics and cybersecurity. Management believes this diversification will create more value than insurance alone by using the steady cash from brokerage commissions to fund faster-growing tech assets.
The most important trend is the company's recent move into positive territory for adjusted earnings, which signals that its cost-cutting efforts are finally working. In Q3 2024, the business reported positive adjusted EBITDA of $42,508, a significant improvement from a $200,602 loss in the same period a year earlier. This shift is driven by the "OneFirm" strategy that has reduced operating losses by 64% over the last year.
Cash generation remains a primary concern as the company still reports a net loss when including non-cash charges like depreciation and stock-based pay. While the operating loss narrowed to $511,977 in the most recent reported quarter, the business is not yet generating enough free cash flow to fund its acquisition-heavy growth strategy without raising new capital. This gap forces the company to rely on issuing new shares, which dilutes existing owners.
The balance sheet is lean but carries risk due to a debt-to-equity ratio of 0.21 and a reliance on warrant liabilities that can fluctuate in value. With a total market value currently hovering at a very low level, the company's ability to borrow more for large acquisitions like Spetner is limited. However, the move toward operating break-even reduces the immediate danger of a cash crunch.
Reliance Global is a business in a fragile transition that has only just begun to prove its financial model can work.
The "OneFirm" integration is successfully lowering the cost of doing business by consolidating back-office functions across different agencies. This led to a 64% reduction in operating losses last quarter even as the company continued to acquire new agencies.
The company must close and integrate the Spetner acquisition without seeing a spike in corporate overhead or a loss of key agents. If this deal fails to double revenue as projected, the company will likely need to raise more cash at a very low stock price.
The US insurance brokerage market is a $160 billion industry that grows at roughly the same rate as the broader economy. While the industry is mature, it is currently undergoing a massive digital shift as small agencies struggle to afford the technology needed to compete with national chains. Pricing power is structural for large brokers who control carrier relationships, but Reliance Global is currently a niche player attempting to carve out a challenger position by providing that technology to the "little guys."
The competitive dynamic in insurance brokerage is brutal for small players because carriers prefer to work with large brokers who can provide high volumes of business. The industry is rapidly consolidating, which forces smaller agencies to either sell out or join a larger network like RELI Exchange just to survive.
Goosehead Insurance is the most direct threat because it also targets the independent agent market but with much more proven scale and profitability. Larger giants like Brown & Brown threaten Reliance by simply outbidding them for the most profitable local agencies, potentially leaving Reliance with lower-quality targets. The most dangerous threat is the rise of direct-to-consumer platforms from major carriers that bypass brokers entirely.
Reliance Global is currently holding ground by targeting the "micro-broker" segment that is too small for the giants to care about. Evidence for this is the 72% growth in health policies written during the 2025 open enrollment period. This growth suggests the platform is gaining traction with its core user base.
Reliance Global does not currently possess a structural moat, as evidenced by its negative operating margins and ROIC. Any protection it has comes from the switching costs associated with its RELI Exchange software, which acts as the operating system for its partner agents. Once an agent moves their entire client list and quoting process onto the platform, leaving becomes a major administrative headache.
The financial metrics prove that these switching costs are not yet high enough to provide pricing power. With a negative gross margin of 4.8%, the company is essentially paying more to service its agencies than it is currently collecting in fees and commissions. The business remains in a cycle where it must achieve much greater scale before these protections translate into profit.
The moat is currently non-existent but could strengthen into a narrow network effect if the agent base grows large enough to demand better commission rates from carriers. The single most important signal will be a move to positive gross margins.
Reached positive adjusted EBITDA in Q3 2024 after years of losses.
Acquired Spetner to double revenue, but relies on share issuance.
CEO Ezra Beyman has led the firm since 2013 and is the primary architect.
Capital Allocation Track Record
Management has successfully pivoted the company from a collection of agencies into a technology-led platform, recently hitting a milestone of positive adjusted earnings. While Ezra Beyman has shown discipline in cutting costs by 64% recently, the move into non-insurance tech through EZRA is a risky distraction for a micro-cap company. The team's ability to integrate the Spetner deal without further diluting shareholders is the final test of their credibility.
We expect revenue to grow from $0.013B in FY2026 to $0.015B in FY2031 (~3% CAGR), with EPS growing from -$0.80 to $0.22 (~128% recovery). Revenue growth is driven by the gradual expansion of the RELIE digital platform which allows for more efficient client acquisition across the brokerage network. Operating margins improve as the company spreads its fixed corporate costs over a stabilized revenue base and reduces redundant administrative roles. Operating margin expected to reach ~10% by FY2031.
Spetner acquisition doubles revenue and creates path to profitability. Doubling revenue to $28 million provides the scale needed to finally cover corporate overhead costs.
RELI Exchange network hits critical mass for carrier negotiations. A larger agent network allows Reliance to demand higher commission rates from major insurance carriers.
EZRA tech portfolio produces a high-margin breakout product. Success in breath-diagnostics or cybersecurity would diversify the business away from thin-margin brokerage.
Failure to integrate Spetner leads to agent churn and revenue loss. If agents leave during the transition, the company will have taken on debt for a shrinking asset.
Dilution from capital raises wipes out gains for current shareholders. Continued net losses may force more share sales at current low prices to fund operations.
Carrier commission compression reduces the take-rate for all brokers. If insurance companies cut the cut they pay to brokers, Reliance's path to profitability vanishes.
Below is our estimate of current and future fair value, with detailed reasoning and assumptions. Fair value is a judgment, not a fact, and other analysts will likely land on different numbers. Use it as one data point in your research, and apply your own discretion in any investing decision.
We use a 5-year Discounted Cash Flow (DCF) model with a terminal value based on an exit multiple. This framework fits Reliance because the company is currently loss-making, making current-year multiples meaningless; the value lies entirely in the projected pivot to profitability through its InsurTech and technology investments.
Our $2 fair value is calculated by discounting the FY2031 projected earnings of $0.22 per share back to the present at a 10% rate. The 15x terminal multiple sits at the lower end of the insurance services peer range (10x–25x) to account for the risks inherent in micro-cap turnarounds. We use the deterministic engine's FY2031 EPS of $0.22 as the basis for this long-term earnings potential.
Cross-checked with a Forward P/E approach using the FY2029 EPS estimate of $0.12 and a 15x multiple, we get a value of $1.80. This result is within 10% of our $2 DCF-based fair value, confirming that the valuation is consistent as the company moves toward its mid-term profitability goals. Both methods suggest the market is currently pricing in a high probability of failure, creating a wide gap between the current $0.25 price and the intrinsic value of the projected earnings stream.
We're assuming the core insurance segment continues to generate at least $0.7 million in quarterly net income. This segment saw 11% year-over-year revenue growth in Q1 2026 and serves as the primary cash engine to fund the company's "OneFirm" operational efficiencies and strategic pivots.
We're assuming the company achieves the milestone-based growth required to reach $0.22 EPS by FY2031. This requires a successful rollout of RELI Exchange 2.0 and disciplined capital allocation toward high-margin technology platforms rather than the capital-intensive traditional brokerage model of the past.
The biggest risk is continued shareholder dilution from equity offerings required to fund the Scale51 expansion. This would increase the total share count and could knock $0.10 to $0.15 off the per-share fair value even if the total company value increases. Watch the "Shares Outstanding" count in the next 10-Q filing for any sudden moves above current levels.
Bear case ($0): Health insurance policy growth through RELI Exchange drops below 20% year-over-year; or Failure to close the Spetner acquisition or integrate the Enquantum cybersecurity stake.
Bull case ($4): Quarterly GAAP profitability is achieved ahead of the FY2028 projection; or Successful spin-off or monetization of technology stakes in cybersecurity or life sciences.
Clearthesis wrote this report from 28 sources, including SEC filings, industry research, and recent news.
How did you like this thesis?
Your feedback helps us make reports better for you
© 2026 Clearthesis.ai · Report generated on June 21, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.